Clinical Study
Influence of Febrile Neutropenia Period on Plasma Viscosity at Malignancy
Table 3
Laboratory results of febrile neutropenic episode and after febrile neutropenic period.
| Parameter | Febrile neutropenic episode | After febrile neutropenic period | | mean SD (median) |
| Plasma viscosity (mPa.s.) | (1.17) | (1.07) | .006 | Leukocyte (/L) | (0.9) | (4.69) | .001 | Neutrophil (/L) | (0.13) | (2.54) | .001 | Hemoglobin (gr/dL) | (9.12) | (9.63) | .177 | Thrombocyte (/L) | (41.00) | (63.95) | .245 | ESR (mm/h) | (33.00) | (27.50) | .323 | Prothrombin time (second) | (14.25) | (14.40) | .283 | Fibrinogen (mg/dL) | (352.00) | (420.50) | .865 | BUN (mg/dL) | (15.50) | (13.05) | .844 | Creatinine (mg/dL) | (0.74) | (0.67) | .213 | Sodium (mmol/L) | (136.00) | (139.00) | .136 | Potassium (mmol/L) | (3.89) | (3.82) | .588 | Uric acid (mg/dL) | (5.33) | (5.15) | .478 | AST (U/L) | (16.50) | (16.10) | .846 | ALT (U/L) | (17.10) | (16.20) | .476 | ALP (IU/L) | (63.20) | (111.70) | .031 | GGT (U/L) | (33.50) | (41.50) | .698 | Total bilirubin (mg/dL) | (1.08) | (1.09) | .927 | Direct bilirubin (mg/dL) | (0.43) | (0.55) | .167 | Total protein (gr/dL) | (5.20) | (5.30) | .268 | Albumin (gr/dL) | (3.01) | (3.20) | .934 | C reactive protein (mg/L) | (54.30) | (48.60) | .948 |
|
|
ESR: erythrocyte sedimentation rate; BUN: blood urea nitrogen; AST: aspartate aminotransferase; ALT: alanine aminotransferase; ALP: alkaline phosphatase; GGT: gamma-glutamyl transferase.
|